NMPA Approval

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Approval Number

国药准字H20233025

Company深圳翰宇药业股份有限公司

Registration Date

January 10, 2023

Drug Information

Generic Name

西格列汀二甲双胍片(Ⅱ)

Dosage Form

片剂

Strength

每片含磷酸西格列汀50mg（以西格列汀计）和盐酸二甲双胍850mg

Drug Type

化学药品

Registration Date

January 10, 2023

Company Information

Applicant Company

Company Name深圳翰宇药业股份有限公司

Company Address

深圳市龙华区观澜高新园区观盛四路7号翰宇创新产业大楼

Manufacturing Company

Company Name甘肃成纪生物药业有限公司

Company Address

甘肃省天水市麦积区廿铺工业示范区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

西格列汀二甲双胍片(Ⅱ) - NMPA 批准文号 | MedPath